Search Results - "Santen, Gijs We"

Refine Results
  1. 1
  2. 2
  3. 3

    Two SMARCAD1 Variants Causing Basan Syndrome in a Canadian and a Dutch Family by Elhaji, Youssef, van Henten, Tessa M.A., Ruivenkamp, Claudia A.L., Nightingale, Mathew, Santen, Gijs WE, Vos, Lydia E., Hull, Peter R.

    Published in JID innovations (01-09-2021)
    “…Basan syndrome is an autosomal dominant genodermatosis characterized by congenital adermatoglyphia, transient congenital facial milia, neonatal acral bullae,…”
    Get full text
    Journal Article
  4. 4

    Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome? by Sun, Yu, Ruivenkamp, Claudia A.L., Hoffer, Mariëtte J.V., Vrijenhoek, Terry, Kriek, Marjolein, van Asperen, Christi J., den Dunnen, Johan T., Santen, Gijs W.E.

    Published in Human mutation (01-06-2015)
    “…ABSTRACT Although the benefits of next‐generation sequencing (NGS) for the diagnosis of heterogeneous diseases such as intellectual disability (ID) are…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    The ARID1B phenotype: What we have learned so far by Santen, Gijs W.E., Clayton-Smith, Jill

    “…Evidence is now accumulating from a number of sequencing studies that ARID1B not only appears to be one of the most frequently mutated intellectual disability…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Finding Suitable Clinical Endpoints for a Potential Treatment of a Rare Genetic Disease: the Case of ARID1B by Kruizinga, Matthijs D., Zuiker, Rob G.J.A., Sali, Elif, de Kam, Marieke L., Doll, Robert J., Groeneveld, Geert Jan, Santen, Gijs W.E., Cohen, Adam F.

    Published in Neurotherapeutics (01-07-2020)
    “…There is a lack of reliable, repeatable, and non-invasive clinical endpoints when investigating treatments for intellectual disability (ID). The aim of this…”
    Get full text
    Journal Article
  12. 12

    A functional assay to classify ZBTB24 missense variants of unknown significance by Wu, Haoyu, Vonk, Kelly K. D., Maarel, Silvère M., Santen, Gijs W.E., Daxinger, Lucia

    Published in Human mutation (01-08-2019)
    “…Increasing use of next‐generation sequencing technologies in clinical diagnostics allows large‐scale discovery of genetic variants, but also results in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Morphine Glucuronidation in Preterm Neonates, Infants and Children Younger than 3 Years by Knibbe, Catherijne A. J., Krekels, Elke H. J., van den Anker, Johannes N., DeJongh, Joost, Santen, Gijs W. E., van Dijk, Monique, Simons, Sinno H. P., van Lingen, Richard A., Jacqz-Aigrain, Evelyne M., Danhof, Meindert, Tibboel, Dick

    Published in Clinical pharmacokinetics (01-01-2009)
    “…Background and objective A considerable amount of drug use in children is still unlicensed or off-label. In order to derive rational dosing schemes, the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Exome Sequencing Identifies A Branch Point Variant in Aarskog-Scott Syndrome by Aten, Emmelien, Sun, Yu, Almomani, Rowida, Santen, Gijs W.E., Messemaker, Tobias, Maas, Saskia M., Breuning, Martijn H., den Dunnen, Johan T.

    Published in Human mutation (01-03-2013)
    “…ABSTRACT Aarskog–Scott syndrome (ASS) is a rare disorder with characteristic facial, skeletal, and genital abnormalities. Mutations in the FGD1 gene (Xp11.21)…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    GPSM2 and Chudley-McCullough Syndrome: A Dutch Founder Variant Brought to North America by Almomani, Rowida, Sun, Yu, Aten, Emmelien, Hilhorst-Hofstee, Yvonne, Peeters-Scholte, Cacha M.P.C.D., van Haeringen, Arie, Hendriks, Yvonne M.C., den Dunnen, Johan T., Breuning, Martijn H., Kriek, Marjolein, Santen, Gijs W.E.

    “…Chudley–McCullough syndrome (CMS) is characterized by profound sensorineural hearing loss and brain anomalies. Variants in GPSM2 have recently been reported as…”
    Get full text
    Journal Article